At least a quarter of cancer patients across Europe who need radiotherapy don’t receive it

07 Nov 2018

Radiotherapy is ‘undervalued’ and ‘needs greater investment’ according to a new report commissioned by the Marie Curie Legacy Campaign – an initiative of the European Society for Radiotherapy and Oncology (ESTRO) and the ESTRO Cancer Foundation (ECF).

‘Radiotherapy saves lives – either used alone or in combination with other types of cancer treatment,’ says report author, Yolande Lievens, Chair of the Department of Radiation Oncology, Ghent University Hospital, and Past-President of ESTRO. ‘Currently, radiotherapy is recommended as part of treatment for more than 50% of cancer patients, but across Europe, at least a quarter of people who need radiotherapy do not receive it. This is wholly unacceptable and a missed opportunity for cancer patients.’

Entitled Radiotherapy: seizing the opportunity in cancer care, the report recommends a five‑point plan to boost uptake of radiotherapy and calls on all stakeholders – governments and policymakers, healthcare professionals, patients and professional societies, along with national and international research funds – to become ‘radiotherapy ambassadors’ to help raise awareness of the benefits of radiotherapy and secure its valuable position in comprehensive, optimal cancer care.

The report’s authors cite shortages of high-quality equipment, variations in training, insufficient integration of radiotherapy into treatment plans, lack of investment in research, lack of general understanding of radiotherapy as a cancer treatment and misconceptions regarding the safety of radiotherapy among the important factors contributing to radiotherapy’s poor image and underuse.

Help improve general awareness and understanding of radiotherapy to ensure it can achieve its full potential for patient care

In 2018, 4.23 million people received a cancer diagnosis in Europe – and the incidence of cancer is increasing.

The demand for radiotherapy is expected to see a 16% increase by 2025.

‘Radiotherapy appears to be left on the sidelines of national health policy agendas,’ says Lydia Makaroff, Director of the European Cancer Patient Coalition. ‘Greater investment, improved access and better understanding of radiotherapy – both at a national and international level – is vital. This will ensure that patients get the best possible and most effective care for their particular type of cancer, leading to better outcomes and more lives saved.’

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.